By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Antiarrhythmic > Amiodarone

Amiodarone

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|613 words

What is Amiodarone?

Amiodarone is a powerful antiarrhythmic medication belonging to the Class III category of heart rhythm drugs. It is primarily used to treat serious, life-threatening irregular heart rhythms (arrhythmias) when other treatments have failed or are not suitable. Due to its potent effects and significant side effect profile, amiodarone is typically reserved for severe cases where the benefits outweigh the substantial risks.

Uses

Amiodarone is approved for several serious cardiac conditions:

  • Ventricular fibrillation: A life-threatening condition where the heart’s lower chambers quiver instead of pumping blood effectively
  • Ventricular tachycardia: Dangerously fast heart rhythms originating in the ventricles that don’t respond to other treatments
  • Atrial fibrillation: Used in certain cases to restore and maintain normal heart rhythm when other medications haven’t worked
  • Atrial flutter: Another type of irregular heartbeat affecting the heart’s upper chambers
  • Prevention of sudden cardiac death: In patients with high-risk heart conditions who haven’t responded to other antiarrhythmic drugs

How it works

Amiodarone works by blocking multiple types of ion channels in heart muscle cells, particularly potassium channels, which prolongs the time it takes for heart cells to reset between beats. This action helps stabilize irregular electrical activity in the heart and prevents dangerous arrhythmias from developing. Unlike many other antiarrhythmic drugs, amiodarone affects multiple pathways in the heart’s electrical system, making it highly effective but also more likely to cause side effects.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Fatigue and weakness
  • Nausea and loss of appetite
  • Constipation
  • Dizziness
  • Sleep disturbances and vivid dreams
  • Tremor or shaking
  • Blue-gray skin discoloration (especially with sun exposure)
  • Sensitivity to sunlight

Serious side effects requiring immediate medical attention:

  • Lung toxicity (cough, shortness of breath, chest pain)
  • Liver damage (yellowing of skin or eyes, severe abdominal pain)
  • Thyroid problems (either overactive or underactive thyroid)
  • Vision problems or optic nerve damage
  • New or worsened heart rhythm problems

Warnings and precautions

  • Pulmonary toxicity: Can cause potentially fatal lung damage, requiring regular chest X-rays and lung function monitoring
  • Thyroid monitoring required: Can cause both hyperthyroidism and hypothyroidism; thyroid function tests needed every 6 months
  • Pregnancy category D: Can harm the developing fetus and should only be used in pregnancy if the life-threatening benefits to the mother outweigh fetal risks
  • Liver function monitoring: Regular blood tests needed to check for liver damage, especially during the first year of treatment
  • Eye examinations: Annual eye exams recommended due to risk of corneal deposits and optic nerve problems

Interactions

Amiodarone has numerous significant drug interactions:

  • Warfarin: Greatly increases bleeding risk by enhancing warfarin’s blood-thinning effects
  • Digoxin: Can double digoxin levels, leading to toxicity
  • Statins: Increases risk of muscle damage and breakdown when combined with cholesterol-lowering drugs
  • Beta-blockers: May cause dangerous slowing of heart rate and blood pressure
  • Calcium channel blockers: Can lead to severe heart rhythm problems or heart failure
  • Phenytoin: Increases seizure medication levels, potentially causing toxicity
  • Cyclosporine: Raises immunosuppressant levels, increasing risk of kidney damage
  • Grapefruit juice: May increase amiodarone levels and side effects

Check interactions with the GMJ Interaction Checker

Dosage

Amiodarone dosing is highly individualized and typically follows a loading and maintenance phase approach. Initial loading doses are usually 800-1600 mg daily for 1-3 weeks, followed by maintenance doses of 200-400 mg daily. For life-threatening arrhythmias, intravenous administration may be used in hospital settings. Due to the drug’s long half-life and complex dosing requirements, all dosing decisions must be made by a cardiologist or other qualified healthcare provider with experience using this medication. Regular monitoring and dose adjustments are essential throughout treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Amiodarone." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/amiodarone/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK Approves 47 New Pharmaceutical Manufacturing and Wholesale Dealer Licences in Latest MHRA Review

UK's MHRA has granted 47 new pharmaceutical manufacturing and wholesale dealer licences…

Eric Edwards, Pioneer of UK Kidney Transplantation, Dies

Eric Edwards, the pioneering British urologist who performed the first cadaver kidney…

UK Approves 47 New Pharmaceutical Manufacturing and Wholesale Dealer Licences in Latest MHRA Review

UK's MHRA has granted 47 new pharmaceutical manufacturing and wholesale dealer licences…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Flecainide

By
Prof. Giorgi Pkhakadze
02/06/2026

Dronedarone

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up